Bahrain authorizes use of Pfizer's anti-COVID drug -state news agency

Bahrain authorizes use of Pfizer's anti-COVID drug -state news agency
  • Country:
  • Egypt

Bahrain's health authorities authorized Pfizer's Paxlovid COVID-19 drug for emergency use in adults aged over 18, the state news agency said in a statement on Saturday.

The decision by the National Authority for Regulating Health Professions and Services was based on the review and evaluation of data provided by Pfizer, the statement added.

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.